<?xml version="1.0" encoding="UTF-8"?>
<document id="26854714">
	<sentence id="s1" text="Further in vitro and in vivo results demonstrated that ALDOA was associated with proliferation and metastasis of pancreatic cancer cells.">
		<entity id="s1.e1" charOffset="55-60"
			type="GENE" text="ALDOA" ontology_id="226"/>
		<entity id="s1.e2" charOffset="124-130"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Moreover, ALDOA predicted poor prognosis of pancreatic cancer, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.">
		<entity id="s2.e1" charOffset="10-15"
			type="GENE" text="ALDOA" ontology_id="226"/>
		<entity id="s2.e2" charOffset="55-61"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1Î± and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.">
		<entity id="s3.e1" charOffset="29-34"
			type="GENE" text="ALDOA" ontology_id="226"/>
		<entity id="s3.e2" charOffset="49-55"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e3" charOffset="93-98"
			type="GENE" text="c-Myc" ontology_id="4609"/>
		<entity id="s3.e4" charOffset="110-114"
			type="GENE" text="NRF2" ontology_id="2551"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p3" e1="s3.e2"
		    e2="s3.e4" pgr="false"/>
	</sentence>
</document>
